Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice

Clinical and Vaccine Immunology

Volumn 13, Issue 2, 2006, Pages 227-234

  Sun, Anyuan ^a   Wei, Haiming ^a   Sun, Rui ^a,b   Xiao, Weihua ^a   Yang, Yongguang ^c   Tian, Zhigang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b SHANDONG UNIVERSITY   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; PHYTOHEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T CELL DEPLETION; T LYMPHOCYTE; THYMUS;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GRAFT ENHANCEMENT, IMMUNOLOGIC; HUMANS; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, SCID; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HETEROLOGOUS;

EID: 33644888011     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.2.227-234.2006     Document Type: Article

References (54)

1. Abedi, M. R., B. Christensson, K. B. Islam, L. Hammarstrom, and C. I. E. Smith. 1992. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur. J. Immunol. 22:823-828.
2. Albert, S. E., C. Mckerlie, A. Pester, B.-J. Edgell, J. Carlyle, M. Petric, and J. W. Chamberlain. 1997. Time-dependent induction of protective antiinfluenza immune responses in human peripheral blood lymphocyte/SCID mice. J. Immunol. 159:1393-1403.
3. Baird, A. M., R. M. Gerstein, and L. J. Berg. 1999. The role of cytokine receptor signaling in lymphocyte development. Curr. Opin. Immunol. 11:157-166.
4. Barry, T. S., D. M. Jones, C. B. Richter, and B. F. Haynes. 1991. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J. Exp. Med. 173:167-180.
5. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-2202.
6. Bombil, F., D. Latinne, J. P. Kints, and H. Bazin. 1996. Human recombinant interleukin-4 (HurIL-4) improves SCID mouse reconstitution with human peripheral blood lymphocytes. Immunobiology 196:437-448.
7. Bykovskaia, S. N., M. Buffo, H. Zhang, M. Bunker, M. L. Levitt, and M. Agha. 1999. The generation of human dendritic and NK cells from hematopoietic progenitors induced by interleukin-15. J. Leukoc. Biol. 66:659-666.
8. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395-1403.
9. Chklovskaia, E., C. Nissen, L. Landmann, C. Rahner, O. Pfister, and A. Wodnar-Filipowicz. 2001. Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A. Blood 97:1027-1034.
10. Coccia, M. A., S. J. Weeks, C. L. Knott, and K. Kuus-Reichel. 1998. Human IL-6 enhances human lymphocyte engraftment and activation but not human antibody production in SCIDhu PBL mice. Immunobiology 198:396-407.
11. Giri, J. G., D. M. Anderson, S. Kumaki, L. S. Park, K. H. Grabstein, and D. Cosman. 1995. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol. 57:763-766.
12. Greiner, D. L., L. D. Shultz, J. Yates, M. C. Appel, G. Perdrizet, R. M. Hesselton, I. Schweitzer, W. G. Beamer, K. L. Shultz, and S. C. Pelsue. 1995. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am. J. Pathol. 146:888-902.
13. Greiner, D. L., R. A. Hesselton, and L. D. Shultz. 1998. SCID mouse models of human stem cell engraftment. Stem Cells 16:166-177.
14. Hesselton, R. M., D. L. Greiner, J. P. Mordes, T. V. Rajan, J. L. Sullivan, and L. D. Shultz. 1995. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type I infection in NOD/LtSz-scid/scid mice. J. Infect. Dis. 172:974-982.
15. Hoffmann-Fezer, G., C. Gall, U. Zengerle, B. Kranz, and S. Thierfelder. 1993. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 81:3440-3448.
16. + T cells. J. Exp. Med. 196:935-946.
17. Kacani, L., G. M. Sprinzl, A. Erdei, and M. P. Dierich. 1999. Interleukin-15 enhances HIV-1-driven polyclonal B-cell response in vitro. Exp. Clin. Immunogenet. 16:162-172.
18. + cells. Blood 102:127-135.
19. Kishida, T., H. Asada, V. Itokawa, F. D. Cui, M. Shin-Ya, and S. Gojo. 2003. Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol. Ther. 8:552-558.
20. Kita, H., I. R. Mackay, J. Van de Water, and M. E. Gershwin. 2001. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120:1485-1501.
21. + T cells. Proc. Natl. Acad. Sci. USA 101:1969-1974.
22. Kondo, M., and I. L. Weissman. 2000. Function of cytokines in lymphocyte development. Curr. Top. Microbiol. Immunol. 251:59-65.
23. Kozar, K., R. Kaminski, A. Giermasz, G. Basak, R. Zagozdzon, and J. Rybczynska. 2002. IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells. Oncol. Rep. 9:427-431.
24. Leclercq, G., V. Debacker, M. de Smedt, and J. Plum. 1996. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 184:325-336.
25. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669-676.
26. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Schultz, M. Lieberman, and I. L. Weissman. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
27. Mehal, W. Z., F. Azzaroli, and I. N. Crispe. 2001. Immunology of the healthy liver: old questions and new insights. Gastroenterology 120:250-260.
28. Mosier, D. E. 1996. Human immunodeficiency virus infection of human cells transplanted to severe combined immuno-deficient mice. Adv. Immunol. 63:79-125.
29. Mosier, D. E. 1996. Viral pathogenesis in hu-PBL-SCID mice. Semin. Immunol. 8:255-262.
30. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259.
31. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1989. On the SCIDs? Nature 338:211.
32. Murphy, W. J., S. K. Durum, M. R. Anver, and D. L. Longo. 1992. Immunological and haematological effects of neuroendocrine hormone: studies on DW/J. dwarf mice. J. Immunol. 148:3799-3808.
33. Murphy, W. J., S. K. Durum, M. Anver, M. Frazier, and D. L. Longo. 1992. Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma. Brain Behav. Immun. 6:355-364.
34. Murphy, W. J., D. D. Taub, and D. L. Longo. 1996. The huPBL-SCID mouse as a means to examine human immune function in vivo. Semin. Immunol. 8:233-241.
35. Murphy, W. J., Z. G. Tian, O. Asai, S. Funakoshi, P. Rotter, and M. Henry. 1996. Chemokines and T lymphocyte activation. II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J. Immunol. 156:2104-2111.
36. Murphy, W. J., S. Funakoshi, W. C. Fanslow, H. C. Rager, D. D. Taub, and D. L. Longo. 1999. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras. Clin. Immunol. 90:22-27.
37. Nonoyama, S., F. O. Smith, and H. D. Ochs. 1993. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes. J. Immunol. 151:3894-3901.
38. Norris, S., C. Collins, D. G. Doherty, F. Smith, G. McEntee, O. Traynor, N. Nolan, J. Hegarty, and C. O'Farrelly. 1998. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28:84-90.
39. + cell development. J. Immunol. 159:5931-5935.
40. Orengo, A. M., E. Di Carlo, A. Comes, M. Fabbi, T. Piazza, M. Cilli, P. Musiani, and S. Ferrini. 2003. Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. J. Immunol. 171:569-575.
41. Perera, L. P., C. K. Goldman, and T. A. Waldmann. 1999. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 162:2606-2612.
42. + hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15. Exp. Hematol. 27:416-424.
43. Plum, J., M. De Smedt, G. Leclercq, B. Verhasselt, and B. Vandekerckhove. 1996. Interleukin-7 is a critical growth factor in early human T-cell development. Blood 88:4239-4245.
44. Roychowdhury, S., B. W. Blaser, A. G. Freud, K. Katz, D. Bhatt, A. K. Ferketich, V. Bergdall, D. Kusewitt, R. A. Baiocchi, and M. A. Caligiuri. 2005. IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood 106:2433-2435.
45. Shpitz, B., C. A. Chambers, A. B. Singhal, N. Hozumi, B. J. Fernandes, C. M. Roifman, L. M. Weiner, J. C. Roder, and S. Gallinger. 1994. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J. Immunol. Methods 169:1-15.
46. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, and D. J. Greiner. 1995. Multiple defects in innate and adaptive immunologic function in NOD/ LtSz-scid mice. J. Immunol. 154:180-191.
47. Tary-Lehmann, M., and A. Saxon. 1992. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med. 175:503-516.
48. Taub, D. D., M. L. Key, D. L. Longo, and W. J. Murphy. 1997. Chemokine-induced human lymphocyte infiltration and engraftment in huPBL-SCID mice. Methods Enzymol. 287:265-291.
49. Toomey, J. A., F. Gays, D. Foster, and C. G. Brooks. 2003. Cytokine requirements for the growth and development of mouse NK cells in vitro. J. Leukoc. Biol. 74:233-242.
50. van den Broeke, L. T., E. Daschbach, E. K. Thomas, G. Andringa, and J. A. Berzofsky. 2003. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J. Immunol. 171:5842-5852.
51. Verma, S., S. E. Hiby, Y. W. Loke, and A. King. 2000. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol. Reprod. 62:959-968.
52. Wu, J., and L. L. Lanier. 2003. Natural killer cells and cancer. Adv. Cancer Res. 90:127-156.
53. Zhang, J., R. Sun, H. Wei, J. Zhang, and Z. G. Tian. 2004. Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK cell-based adoptive cellular immunotherapy. Oncol. Rep. 11:1097-1106.
54. Zhang, J., R. Sun, H. Wei, J. Zhang, and Z. G. Tian. 2004. Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy. Haematologica 89:338-347.